SCHEMBL25545222

SCHEMBL25545222

COc1cc(-c2nc(Nc3ncc(-c4cccs4)cc3C(=O)O)sc2CC(C)C)ccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ KDM4E B2RXH2 5/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ NEK2 P51955 1/20 0.40
▸ PTGDR2 Q9Y5Y4 5/20 0.39
▸ MAPT P10636 6/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ CACNA1B Q00975 2/20 0.38
▸ APBA1 Q02410 2/20 0.38
▸ PDGFRB P09619 1/20 0.36
▸ PDGFRA P16234 1/20 0.36
▸ GAA P10253 3/20 0.36
▸ PGK1 P00558 1/20 0.36
▸ CDK2 P24941 1/20 0.35
▸ FTO Q9C0B1 1/20 0.35
▸ HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25545231 0.93 KDM4E (0.41) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25545227 0.93 KDM4E (0.36) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25545274 0.93 ALDH1A1 (0.39) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25545298 0.92 ALDH1A1 (0.40) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25545229 0.91 ALDH1A1 (0.40) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25545302 0.91 ALDH1A1 (0.41) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25560435 0.91 ALDH1A1 (0.41) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25545019 0.89 TNFRSF1A (0.40) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25544983 0.89 ALDH1A1 (0.39) ALDH1A1KMT2AKDM4ERAB9AMEN1
SCHEMBL25545235 0.89 NEK2 (0.41) ALDH1A1KMT2AKDM4ERAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 ALDH1A1 4776/4885KMT2A 1931/4885KDM4E 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback